skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

49 studies were found about ( dolutegravir OR GSK1349572 )

Compassionate Use of Dolutegravir and Ibalizumab for the Treatment of HIV Infection

Condition: Human Immunodeficiency Virus (HIV)

NCT ID: NCT02028819

Safety of and Immune Response to Dolutegravir (GSK1349572) in HIV-1 Infected Infants, Children, and Adolescents

Condition: HIV Infections

NCT ID: NCT01302847

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00951015

A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00950859

Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00708110

Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Protease Inhibitors To Dolutegravir In HIV-1-Infected Subjects With Low Bone Mineral Density

Condition: HIV-1 Infection

NCT ID: NCT01966822

Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD)

Condition: HIV-1 Infection

NCT ID: NCT02067767

Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01568892

Cardiovascular Risk in HIV Patients Switching From a Boosted Protease Inhibitor (PI) to Dolutegravir (DTG)

Condition: HIV

NCT ID: NCT02098837

A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01910402

A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01499199

A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01328041

Dolutegravir + Rilpivirine Switch Study (DORISS)

Condition: HIV Infection; HAART-treated; Virologically Controlled

NCT ID: NCT02069834

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01449929

GSK1349572 Relative Bioavailability Study

Condition: HIV Infections

NCT ID: NCT01098513

A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT01263015

A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT01227824

Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers

Condition: HIV Infections

NCT ID: NCT01068925

Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam

Condition: HIV-infection/AIDS

NCT ID: NCT01827540

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01231516

Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.

Condition: Infections, Human Immunodeficiency Virus and Hepatitis

NCT ID: NCT01467518

Dolutegravir Expanded Access Study

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01536873

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01332565

A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT02105987

A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects.

Condition: Human Immunodeficiency Virus I Infection

NCT ID: NCT01283100

Relative Bioavailability Study of a Pediatric Granule Formulation of Dolutegravir

Condition: Infections, Human Immunodeficiency Virus and Herpesviridae

NCT ID: NCT01382238

A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects

Condition: Infections, Human Immunodeficiency Virus and Hepatitis

NCT ID: NCT01467531

Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01231542

GSK1349572 Hepatic Impairment Study

Condition: Healthy Subjects; Hepatic Impairment; Infection, Human Immunodeficiency Virus

NCT ID: NCT01231529

GSK1349572 Drug Interaction Study With Protease Inhibitors

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT00774735

Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01498861

Dolutegravir Renal Impairment Study

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01353716

Drug Interaction Study Between Dolutegravir and Prednisone

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01425099

A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01563328

Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT01366547

Evaluation of the Bioequivalence of a Combined Formulated Tablet

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01622790

GSK1349572 Drug Interaction Study With Efavirenz

Condition: Infections, Human Immunodeficiency Virus and Herpesviridae; Healthy

NCT ID: NCT01098526

GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir

Condition: Infections, Human Immunodeficiency Virus and Herpesviridae

NCT ID: NCT01209065

A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects

Condition: Infections, Human Immunodeficiency Virus and Tuberculosis

NCT ID: NCT01214993

Effect of Dolutegravir on Metformin Pharmacokinetics in Healthy Adult Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT02064374

A Prospective, Non-interventional Study of the Use of Dolutegravir as Part of Combination Antiretroviral Therapy in Routine Daily Practice in Germany

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT02076386

A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01762995

Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01967771

Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT02082808

ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT02075593

Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load

Condition: HIV Infections

NCT ID: NCT01933594

Pharmacokinetics, Safety, and Efficacy of Cobicistat-boosted Atazanavir or Cobicistat-boosted Darunavir in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects

Condition: Acquired Immune Deficiency Syndrome (AIDS); HIV Infections

NCT ID: NCT02016924

GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study

Condition: Healthy Volunteer

NCT ID: NCT00942136

GSK1349572 Exposure in Blood, Seminal Fluid, and Rectal Fluid and Tissue in Healthy Male Subjects

Condition: Healthy

NCT ID: NCT01459315